Acorn Cardiovascular, Inc., a medical device company, develops treatments for patients with heart failure. Its product includes CorCap cardiac support device, a mesh warp that is implanted around the heart to provide ventricular support and reduce ventricular wall stress in patients with dilated cardiomyopathy and symptomatic heart failure. The company was incorporated in 1996 and is based in St. Paul, Minnesota.

Paracor Medical is an innovative medical device company focused on providing unique, technology-driven solutions for the treatment of heart failure. Founded in 1999, Paracor was established to pursue new and innovative ways to treat heart failure (HF) that would not require the patient to undergo open chest surgery. Paracor engineers recognized that a mechanical approach to reducing the workload of a failing, diseased heart muscle could be a new and effective solution.

Mardil Medical is a medical device company, develops therapies for structural heart diseases. It offers therapies for abnormalities in the shape of the heart muscle or valves. The company provides VenTouch, a targeted ventricular reshaping system that addresses the root cause of functional mitral valve regurgitation. Its VenTouch system is a conforming jacket that surrounds the heart’s pumping chambers and normalizes their shape with anatomy correcting the adjustability feature. Mardil Medical was incorporated in 2001 and is headquartered in Plymouth, Minnesota.

Cardiac Pacemakers, Inc.(CPI), doing business as Guidant Cardiac Rhythm Management, manufactured implantable cardiac rhythm management devices, such as pacemakers and defibrillators. It also sold insulin pumps controlled by microprocessors and various equipments to regulate heart rhythm. In addition, Cardiac Pacemakers, Inc. developed therapies for the treatment of irregular heartbeats. The company was founded in 1971 and is based in St. Paul, Minnesota. Cardiac Pacemakers, Inc. operates as a subsidiary of Boston Scientific Corporation.

St. Jude Medical, Inc. was an American global medical device company headquartered in Little Canada, Minnesota, U.S., a suburb of Saint Paul. The company had more than 20 principal operations and manufacturing facilities worldwide with products sold in more than 100 countries. Its major markets include the United States, Europe, Latin America and Asia-Pacific. The company was named after Jude the Apostle, the patron saint of lost causes.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Acarix A/S is based on pioneering research performed at the Aalborg University, Denmark, initiated in 2004. The research group received the award, ‘MedicoPrisen’, from Medicoindustrien (Danish Medtech trade association) in 2007. A research and development collaboration was established in 2007 between Aalborg University and Coloplast A/S, receiving public support from the Danish National Advanced Technology Foundation in 2008. Acarix A/S was established in 2009 as a spin-out company from Coloplast A/S with Coloplast A/S and Aalborg University as the major shareholders. In 2010 Acarix A/S succeeded attracting venture capital from Seed Capital (DK), Sunstone Capital (DK) and Seventure Partners (F). In 2011 Acarix A/S and collaborators furthermore achieved funding of 5.3 million DKK from the Danish Business Innovation Fund.

Suzhou Rainmed Medical Technology Co., Ltd. is a company headquartered in Nano, China, with subsidiaries in that country. The firm develops surgical robotic equipment. It was founded in 2014. Yong Hui Lyu and Yun Fei Huo are the current co-CEOs of the company.

CorAssist is a clinical stage medical device company committed to developing innovative therapeutic products for treating Heart Failure with Preserved Ejection Fraction. The company's proprietary technology enables the first implantation of a device that directly improves cardiac diastolic function. CORolla®, is an elastic self-expanding internal spring-like device implanted inside the left ventricular, through a Transapical or percutaneous procedure. The device assists diastolic function by improving diastolic dynamics and filling performance, and does not require an external power source. ImCardia® , the company's first product, is an elastic self-expanding device that is attached to the external left ventricular surface, through a simple off pump procedure.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Synergio is an expert consultancy in the area of corporate responsibility (CR) strategies. Synergio delivers strategic solutions, insights and advice to companies, enabling them to create long-term value by doing business sustainably. Synergio's deep knowledge of challenges and opportunities in sustainability ensures that they have the right tools and strategies to deliver solutions for responsible businesses. Working with diverse clients, Synergio navigate non-financial risk issues and utilise opportunities to gain competitive advantage. With a focus on achieving outcomes and a willingness to embrace innovation, Synergio pushes the boundaries for high engagement approaches in sustainability. Synergio's work has a strong commercial focus and is founded on evidence-based analyses and decision-making. Synergio's knowledge and expertise in environmental, social and economic issues, combined with their consulting, strategy and management experience, enables them to successfully integrate sustainability into business strategies to improve organisational performance. Synergio guides clients through the various stages of their sustainability journey whilst inspiring and facilitating the creation of overarching vision, goals, and long-term plans. Synergio also creates the business case for specific initiatives and recommend governance structures and measurement tools to ensure they are implemented effectively.

HeartWare, Inc. manufactures electro medical and electrotherapeutic apparatus. The company develops implantable circulatory assist devices, which are used in treating patients with congestive heart failure problems. The company was established in 2003 and is headquartered in Miramar, FL

Part of Canon, Inc., Toshiba Medical Systems Co. Ltd. is a Malaysian company located in Penang that develops and manufactures digital imaging and scanning technologies to the medical sector.

CorInnova Incorporated provides device-based therapies for the treatment of congestive heart failure. CorInnova’s non-blood-contacting soft robotic cardiac assist device could potentially triple or quadruple the number of heart failure patients who could be eligible for such a life-saving device therapy.”

TC1 LLC, part of Abbott Laboratories, is a company headquartered in the United States that manufactures blood pressure apparatus.

Harmony Development Group is a heart-focused MedTech company. It works within the ventricle, functioning as an integrated systolic assist system that leverages the native energy of the heart. Their therapies work by aiding and supporting the diseased ventricle, restoring its natural shape, pressure, and flow.

Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.